Abagovomab
Abagovomab (Anti-Human CA-125 Recombinant Antibody) is a murine monoclonal anti-idiotypic antibody, against the tumor-associated antigen, CA-125. Abagovomab is generated by a mouse hybridoma, can imitate the human TAA, CA-125. Abagovomab can elicit humoral and cellular immune responses against ovarian cancer (oc) [1][2].
Product Specifications
CAS Number
792921-10-9
Product Name Alternative
Anti-Human CA-125 Recombinant Antibody
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/abagovomab.html
Purity
95.00
Solubility
10 mM in DMSO
Smiles
[Abagovomab]
Molecular Weight
(144.42 kDa)
References & Citations
[1]Pfisterer J, et al. The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR. Ann Oncol. 2006 Oct;17 (10) :1568-77.|[2]Grisham RN, et al. Abagovomab: an anti-idiotypic CA-125 targeted immunotherapeutic agent for ovarian cancer. Immunotherapy. 2011 Feb;3 (2) :153-62.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC424011 20 µg
NHP2L1 (SNU13) (NM_001003796) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC881687-500 1x 500 µL
VEGF (Vascular Endothelial Growth Factor) (VG76e), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
AP53313PU-N 400 µL
RNF70 (PJA1) (N-term) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details 